Implanted pump improves chemotherapy survival rates
This article was originally published in Clinica
Patients with implanted chemotherapy pumps show significantly increased survival rates over those receiving traditional chemotherapy after surgery for metastatic liver cancer, according to two US studies. As a result, the pump should be used as the standard treatment for liver metastases from colorectal cancer, Dr Elin Sigurdson of Fox Chase Cancer Center told oncologists this week at the Society of Surgical Oncology's annual cancer symposium in New Orleans, Louisiana.
You may also be interested in...
After urging the US Congress to act on updating Medicare Part D, the Association for Accessible Medicines has welcomed the decision to update Part D by the Centers for Medicare & Medicaid Services of the US Department of Health and Human Services.
Dr Reddy’s signals a sharp step up in ambitions at home, propelled by building leadership in 10 therapy segments and an “India-first” approach for specialty products. Uptick in the China business and the potential launch of a Russia-partnered COVID-19 vaccine were other aspects of the business discussed at JPM.
“You can’t just live off the brand equity anymore,” warned J&J's Consumer Health's Minoj Raghunandanan during the ‘Advancing Trust in the Self-Care Industry’ webinar co-hosted by the Global Self-Care Federation and HBW Insight. “You’ve got to continue to build that trust between consumers and products day-in day-out.”